Samir Zughni Email

Site Director, Clinical Operations . Odonate Therapeutics

Current Roles

Employees:
46
Revenue:
$9.3M
About
Odonate Therapeutics is dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer. Our initial focus is on the development of tesetaxel, an investigational, orally administered taxane. We are conducting our multinational, multicenter, randomized, Phase 3 study in locally advanced or metastatic breast cancer (MBC), known as CONTESSA. Our goal is to develop an effective chemotherapy choice for patients that provides quality-of-life advantages over current alternatives.
Odonate Therapeutics Address
4747 Executive Drive
San Diego, CA
United States
Odonate Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.